Epidemiological and clinical characteristics of patients who died from Influenza A(H1N1)pdm09 in Viet Nam

Authors

  • Phan Thanh Tinh Viet Nam Field Epidemiology Training Programme.
  • Phan Trong Lan
  • Patel Mahomed
  • Tran Minh Nhu Nguyen

DOI:

https://doi.org/10.5365/wpsar.2011.2.3.003

Abstract

We describe the epidemiological and clinical characteristics of patients who died from influenza A(H1N1)pdm09 in hospitals in Viet Nam between August 2009 and March 2010.

Of 58 fatal cases, 32 (55%) were below 30 years of age and 14 (24%) were pregnant females. Forty-five (78%) patients had at least one underlying medical condition including chronic heart, kidney or lung diseases or pregnancy. Twelve (21%) cases sought medical attention on the day of symptom onset. Only 13 (36%) of 36 cases for whom treatment data were available had been given antiviral drugs within the recommended two days of symptom onset.

The clinical and epidemiologic characteristics of the patients who died from influenza A(H1N1)pdm09 are similar to those reported from other countries. To improve preparedness and response to future pandemics, Viet Nam needs to strengthen the surveillance of influenza; increase laboratory capacity to test for influenza viruses; and develop strategies for promoting the timely attendance of at-risk individuals at health facilities and the early administration of antiviral drugs, particularly for persons with underlying medical conditions and pregnant females.

Downloads

How to Cite

1.
Tinh PT, Lan PT, Mahomed P, Nhu Nguyen TM. Epidemiological and clinical characteristics of patients who died from Influenza A(H1N1)pdm09 in Viet Nam. Western Pac Surveill Response J [Internet]. 2013 May 30 [cited 2026 Mar. 25];3(1). Available from: https://ojs.wpro.who.int/ojs/index.php/wpsar/article/view/135

Issue

Vol. 3 No. 1 (2012): January – March

Section

- Surveillance Report

License

You are free to:

  • Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
  • Adapt — remix, transform, and build upon the material for any purpose, even commercially.
  • The licensor cannot revoke these freedoms as long as you follow the license terms.

Under the following terms:

  • Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

Notices:

When the Licensor is an intergovernmental organization, disputes will be resolved by mediation and arbitration unless otherwise agreed.

You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation.

No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.

Most read articles by the same author(s)